Skip to content

The Feasibility Study of the Randomized Cancer Screening Trial in China

The Feasibility Study of the Randomized Cancer Screening Trial in China

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007160
Enrollment
Unknown
Registered
2015-09-14
Start date
2014-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Arm 1 for T0:LDCT+Colonoscopy
Arm 2 for T0:LDCT+OC-FIT
Arm 3 for T0 :Septin9+InSureFIT
Arm 1 for T1:LDCT
Arm 2 for T1:OC-FIT
Arm 3 for T1:Septin9+InSureFIT
Arm 1 for T2:LDCT
Arm 2 for T2:LDCT+OC-FIT
Arm 3 for T2:Septin9+InSureFIT

Sponsors

Cancer Hospital, Chinese Academy of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 74 Years

Inclusion criteria

Inclusion criteria: (1) Inhabitant; (2) Age 55–74 at entry; (3) >30 pack-years of smoking, or women living/working with smoker for 20 years; (4) Former smoker quit less than 15 years ago; (5) No history of lung cancer or colorectal cancer; (6) Not had a CT scan of the chest or lungs within the last 24 months; (7) No history of having any of the lung or colorectal screening tests during the past 24 months; (8) Not currently under treatment for any cancer, other than non-melanoma skin cancer; (9) No mental disorder; (10) All people joined this study with informed consents.

Exclusion criteria

Exclusion criteria: (1) Participates who are in poor mental andphysical cannot tolerate screening; (2) Participates who have signed another clinical trial will be excluded.

Design outcomes

Primary

MeasureTime frame
recruitment success;randomization;participant criteria andretention;outcome capture;positivity rates;incident cancer cases;

Countries

China

Contacts

Public ContactJie He
hejie@cicams.ac.cn+86 010-87788207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026